trending Market Intelligence /marketintelligence/en/news-insights/trending/2fa13DWvJysOOmqzNIXisQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Alexion names CEO

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Alexion names CEO

Alexion Pharmaceuticals Inc. appointed Ludwig Hantson as its CEO.

Hantson, who also joins the Alexion board, is the former president and CEO of Baxalta Inc., a Baxter International Inc. spinoff. He succeeds David Brennan, Alexion's interim CEO.

Brennan will remain on Alexion's board of directors and is expected to be appointed the chairman of the company at the upcoming annual meeting May 10.